Adamas Pharmaceuticals Inc. (ADMS) News Nov 20, 20

Adamas Pharmaceuticals Inc. (ADMS) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on ADMS
No News currently available for ADMS

Other News on ADMS
10-Q: ADAMAS PHARMACEUTICALS INC 4:07 p.m. Nov. 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Genervon ALS drug shows encouraging results 7:27 a.m. Oct. 20, 2014 - Seeking Alpha
10-Q: ADAMAS PHARMACEUTICALS INC 3:41 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Forest Laboratories Nabs Pediatric Exclusivity for Namenda - Analyst Blog 12:20 p.m. June 19, 2014 - Zacks.com
Will Forest Labs Retain Namenda Market Share? - Analyst Blog 11:00 a.m. June 13, 2014 - Zacks.com
Milestone Payments for Adamas - Analyst Blog 4:10 p.m. May 22, 2014 - Zacks.com
Adamas trading below IPO price 12:34 p.m. April 14, 2014 - Seeking Alpha
Weibo Leads 10 New Stocks to Watch This Week 8:30 a.m. April 14, 2014 - InvestorPlace.com
IPO Frenzy Freezes As 4 New Issues Delayed 5:05 p.m. April 11, 2014 - Investors Business Daily
Biotech IPOs Adamas, Cerulean Slump In Trading Debut 2:02 p.m. April 10, 2014 - Investors Business Daily
IPO Preview: Adamas Pharmaceuticals 12:33 a.m. April 10, 2014 - Seeking Alpha
13 New Stocks to Watch: Ally Financial, La Quinta on Deck 9:12 a.m. April 7, 2014 - InvestorPlace.com
Busy IPO Calendar Cheatsheet 7:12 a.m. April 1, 2014 - Seeking Alpha
Watchlist: Five IPOs Scheduled for April 10-14, 2014 4:43 p.m. March 31, 2014 - GuruFocus.com
Press Releases on ADMS
Adamas Pharmaceuticals to Present at Piper Jaffray Healthcare Conference 12:01 p.m. Nov. 18, 2014 - GlobeNewswire
Adamas Pharmaceuticals to Present at 2014 Credit Suisse Healthcare Conference 4:01 p.m. Nov. 5, 2014 - GlobeNewswire
Adamas Reports Third Quarter 2014 Financial Results 4:04 p.m. Nov. 4, 2014 - GlobeNewswire
Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients With Parkinson's Disease 3:01 p.m. Oct. 28, 2014 - GlobeNewswire
Adamas Pharmaceuticals Announces Management Changes 3:06 p.m. Aug. 13, 2014 - GlobeNewswire
Adamas Reports Second Quarter 2014 Financial Results 3:26 p.m. Aug. 7, 2014 - GlobeNewswire
United States Patent Issued to Adamas Pharmaceuticals 3:07 p.m. Aug. 5, 2014 - GlobeNewswire
Adamas Pharmaceuticals To Present At JMP Securities Healthcare Conference 2014 3:01 p.m. June 16, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Announces Rater Training Data on ADS-5102 for Parkinson's Disease Patients with Levodopa-Induced Dyskinesia 7:31 a.m. June 10, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Initiates Phase 3 Trial For ADS-5102 In Parkinson's Disease Patients With Levodopa-Induced Dyskinesia 3:01 p.m. June 9, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Announces Data Update At The International Congress Of Parkinson's Disease And Movement Disorders 3:05 p.m. May 29, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Receives $25 Million Milestone Payment From Forest Laboratories 3:05 p.m. May 20, 2014 - PR Newswire - PRF
Adamas Reports First Quarter 2014 Financial Results 3:00 p.m. May 13, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Provides Data Update On ADS-5102 At The American Academy Of Neurology Annual Meeting 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Announces Data Update At American Academy Of Neurology Annual Meeting 3:00 p.m. April 23, 2014 - PR Newswire - PRF
Adamas Pharmaceuticals Announces Closing of Its Initial Public Offering 3:00 p.m. April 15, 2014 - PR Newswire - PRF